The markets have gone ballistic on positive news of a COVID-19 vaccine, but investors are buying in all the wrong places.
The COVID-19 Vaccine Stocks to Buy Right Now
Here are the best COVID-18 vaccine stocks to buy…
Category
DR Barton Jr
Buy Now: MSFT and GOOGL Will Soar Under Divided Government (the Gains Are Already Starting)
As of midday Thursday, we've still got no definitive result from the Nov.
3 election.
Indeed, it's still anyone's game.
And the markets are loving it.
So D.R.
appeared on FOX Business' Varney & Co.
to talk about why stocks were rallying with so much up in the air, and he even named the two stocks he thinks will be truly outstanding performers in this environment…
Buy These Stocks, Sell These, and Watch This Critical Number
Unfortunately, the political and personal fault lines in the United States are about as raw and volatile as they've ever been. But that's a subject for another time and place.
As investors, whatever our personal politics or feelings are, now is the time to quickly come to terms with what's happening and what likely will happen in the stock market.
Because despite the market's action yesterday, it has drawn a line of its own – a "line in the sand" – and where your money is in relation to this line will make a big difference.
I'm going to show you where that line lies, because there are some dangers, no doubt, but there are also some unique profit opportunities… Full Story
The Profitable Move to Make as We Wait Around for Stimulus
The market's big struggle right now, its driving narrative, is between COVID-19 and the prospects of a new, multitrillion-dollar round of stimulus.
Stocks have rebounded over the past two days, after an apparent improvement in the president's COVID-19 symptoms merited his discharge from Walter Reed National Military Medical Center.
On the coronavirus front, investors seem to have digested the bigger picture: The virus remains a severe threat and a major disruptor, but death rates are declining right now, better therapeutics are available, and several vaccine candidates are on the horizon.
Against this backdrop, we've seen no convincing signs of progress in House Speaker Nancy Pelosi's and Treasury Secretary Steven Mnuchin's negotiations over a fresh multitrillion-dollar round of stimulus. The rally lost some significant "steam" on Tuesday after U.S. Federal Reserve Chair Jerome Powell and Speaker Pelosi stressed the need for fresh stimulus, then began a much steeper dive minutes after Trump said negotiations were off until after the November election.
White House-watchers and Wall Street insiders opined that Trump's abrupt move was likely a negotiating tactic, not the end of the stimulus road.
That's established the pattern investors will have to contend with: pullbacks, driven by stimulus worries, will be promptly followed by rallies, as coronavirus fears ease. Rinse and repeat, until further notice.
I'll tell you what I think of our stimulus chances, where the market will go next, and most importantly, the one profitable play you can make right now… Full Story
Your "Winter Survival Plan" Means Avoiding These Six Stocks Now
The warm summer weather allowed people and restaurants to enjoy outdoor activities safely.
But now with the onset of fall and dropping temperatures, COVID-19 cases are resurging.
In fact, four sectors are going to be hit hard this fall and winter.
So D.R.'s showing you the six stocks to avoid now in his "Winter Survival Plan" to ensure your portfolio is well-insulated….
My Favorite Coronavirus Vaccine Candidate Doesn’t Have to Finish First
It might be too early to call it "a light at the end of the tunnel," but the quest for a novel coronavirus vaccine has entered a new, perhaps decisive phase.
We knew fairly quickly after the pandemic exploded that life in most places could never be as it was until an effective vaccine or therapy was produced.
And now we're beginning to get a picture – tentative, to be sure – of when and how that might happen.
Infectious disease expert Dr. Anthony Fauci has said he expects FDA emergency approval of some kind of vaccine by November or December of this year.
Taking it a step further, both Bill Gates and CDC Director Dr. Robert Redfield have indicated the logistics of vaccine distribution will mean life "will start to return to normal" by second and third quarters of 2021, or roughly 18 months after the social and economic devastation of this crisis started.
That seems like an awfully long time, and of course it is, but, as of now, the current "speed record" holder in the vaccine stakes belongs to Merck & Co. Inc.'s Mumpsvax.
And when I say "speed record," understand that it took nearly five years to develop Mumpsvax back in the 1960s.
For us to have an effective vaccine – any vaccine – by the end of 2020, or a little over a year since the disease emerged, would be a breathtaking, unparalleled scientific achievement.
There are dozens upon dozens of different vaccines and therapies being researched all over the world, all in different stages. The market, however, is paying the closest attention to just a few.
Aside from AstraZeneca Plc. in the United Kingdom, there are two frontrunner candidates in the United States, both in late, phase 3 clinical trials.
There's Moderna Inc., whose shares have soared as high as 400%, and Pfizer Inc., which has been rather more subdued this year, but whose vaccine candidate is a favorite in some circles for the first emergency approval.
With that said, the stock I'm going to name might not be first, but it may very well be the best… Full Story
With that said, the stock I'm going to name might not be first, but it may very well be the best...
Here's Another Buffett-Worthy Gold Play
Gold is near $2,000-plus all-time highs, so it's no surprise that investing legend Warren Buffett is riding alongside gold's bull run. But nobody seems to know about another class of gold plays to make right now, giving us more upside potential in this specific stock…
How to Avoid the Market’s Stimulus “Kodak Moment” and What to Do Instead
Back in my college days as a chemical engineering student, I found myself driving down to Kingsport, Tenn. I was due to start a cooperative education job at the Eastman Kodak chemical plant there.
I remember looking at the biggest chemical plant in the world with awe (13,000-plus employees at the time). Kodak sold off its chemical business – now Eastman Chemical – in 1994.
This former employer of mine has been in the news a lot lately. Through a $765 million loan from the Trump administration, it was set to revive the U.S. pharmaceutical industry.
As the news hit and the Robinhood trading crowd piled in, shares soared from $2 to more than $60 in two short days. Hope and optimism ruled.
A few days later, reality set in. The stock cratered. It's now around $10 and trending down.
This is an example of what we in the trading world call "Buy the Rumor, Sell the News."
When a rumor first hits the news feeds, it creates excitement and optimism. Stocks rise, and other traders don't want to miss out.
But things are rarely as rosy as they look at first glance. Once reality sets in, excitement gives way to reason. People start looking into the actual details of the matter.
And more often than not, it turns out that in their excitement, traders overshot.
Kodak's pharmaceutical loan was one example.
But that's small potatoes compared to what's coming next. Kodak was just one company.
This time, stock markets as a whole could be in for a "sell the news" moment. That's why today, I'm going to show you how to avoid the hype and what to do instead to come out on top… Full Story
This Is the Key to Long- and Short-Term Gold and Silver Gains
Precious metals like silver and especially gold have had a stellar year, to put it mildly.
The physical bullion-backed SPDR Gold Trust ETF, probably the easiest way to invest in gold, is up more than 30% this year.
If you bought it at the March bottom, you'd be up even more, nearly 37% or so.
Since the last great gold bull market ended in 2011, this is the most movement (and most profit) gold investors have seen.
It's undeniably exciting.
Thanks to the bull run, gold seems to be everywhere; Wall Street is talking about it again, ads for gold are everywhere on television, and mobile app-based traders are piling in.
In the long term, they're absolutely right: Gold and silver will keep rising, and I'll show you why.
But do not join the crowd. At least not yet. What's unfolding right now will burn many overeager traders before it creates a big buying opportunity.
The real short-term opportunity I'll show you in a minute holds even bigger profit potential, and it won't be long in coming… Full Story
China's Aggressive Moves Are a Profit Catalyst Here
The other day, I pointed out some low-risk ways Americans can profit on the bull run underway in China – a market also buoyed by stimulus and a flood of cash coming in from the sidelines.
But I also warned of some very serious issues between the United States, the rest of the world, and China.
Europe's reopening, America's further slide into COVID-19, and the upcoming election have dominated headlines and news screens for weeks now.
As Big Media relegates China to the status of "background noise," there's a lot you're not hearing about China right now.
It's my job to address that and show you how you can position yourself for profits amid chaos that's going on practically behind our backs right now… Full Story